Magnetic Insight, Inc.
1010 Atlantic Ave
14 articles with Magnetic Insight, Inc.
A MOMENTUM™ Magnetic Particle Imaging (MPI) Scanner by Magnetic Insight has been installed at the Preclinical Imaging Facility at the Karolinska Institutet in Stockholm, Sweden.
Magnetic Insight installs new HYPER localized magnetic theranostic system at Johns Hopkins University
Magnetic Insight has installed a localized magnetic theranostic system at Johns Hopkins University to support an National Institutes of Health-funded project to develop precision-guided magnetic fluid hyperthermia.
The first East Coast installation of the MOMENTUM Magnetic Particle Imaging (MPI) scanner has been completed at Kennedy Krieger Institute in Baltimore, MD.
The article “Tracking adoptive T cell immunotherapy using magnetic particle imaging” has been published in the journal Nanotheranostics (2021, vol 5.). This promising research was concluded using the MOMENTUM™ imager from Magnetic Insight to track the T cells inside a mouse migrating to a brain tumor.
For the second year, Magnetic Insight has hosted the Rising Stars of Magnetic Particle Imaging eSymposium to highlight significant research in the field of magnetic particle imaging (MPI).
Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that David Panzarella has been appointed as the company's Chief Commercial Officer.
Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research grant from the National Cancer Institute of the National Institutes of Health under Award Number R43CA233155.
Magnetic Insight Introduces MOMENTUM CT, the First Commercial Magnetic Particle Imaging (MPI) System with Integrated X-ray Computed Tomography (CT)
Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality
Magnetic Insight Announces Corporate Headquarters Expansion to a State-Of-The-Art 22,000 Square-Foot Facility
The 22,000 square-foot facility provides increased manufacturing capacity for magnetic particle imaging (MPI) systems while enabling new product development and operations.
Development of a Neurovascular Magnetic Particle Imaging system for non-radiative 3D perfusion angiography supported by the National Institutes of Health with a Phase II SBIR award to Magnetic Insight
Magnetic Insight, Inc., leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research Phase II grant from the National Institute of Drug Abuse of the National Institutes of Health under Award Number 2R44DA041814.
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Magnetic Insight, Inc., a developer and manufacturer of transformational in vivo imaging platforms, announced a Series A financing led by 5AM Ventures.
National Institutes of Health Awards Magnetic Insight with a $1.5M Phase II SBIR grant to support the first commercial multimodal preclinical magnetic particle imaging system
Magnetic Insight, Inc., leader in magnetic particle imaging (MPI) solutions, announced today that it was awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Number R44EB020463.
Magnetic Insight Release: Medical Device Company Signs Agreement With inviCRO To Support Imaging Analysis Tools For Quantitative Magnetic Particle Imaging
Magnetic Insight Announces Oversubscribed $3M Fundraising Round To Empower Researchers With Novel Magnetic Particle Imaging Technology